LACTOSE (INDIA)
Back to Balance Sheet
|
LACTOSE (INDIA) Last 5 Year Total Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Liabilities | ₹101 Cr | ₹101 Cr | ₹90 Cr | ₹88 Cr | ₹84 Cr |
What is the latest Total Liabilities ratio of LACTOSE (INDIA) ?
Year | Total Liabilities |
---|---|
Mar2024 | ₹101 Cr |
Mar2023 | ₹101 Cr |
Mar2022 | ₹90 Cr |
Mar2021 | ₹88 Cr |
Mar2020 | ₹84 Cr |
How is Total Liabilities of LACTOSE (INDIA) Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹101 Cr | -0.54 | |
Mar2023 | ₹101 Cr | 12.27 | |
Mar2022 | ₹90 Cr | 2.13 | |
Mar2021 | ₹88 Cr | 5.17 | |
Mar2020 | ₹84 Cr | - |
Compare Total Liabilities of peers of LACTOSE (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
LACTOSE (INDIA) | ₹124.4 Cr | 0.8% | -1.1% | -42.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹393,383.0 Cr | 2.6% | -5.1% | -6.4% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,026.0 Cr | -0.5% | -10.1% | 21.8% | Stock Analytics | |
CIPLA | ₹126,159.0 Cr | 4.7% | 4.8% | -4.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹122,450.0 Cr | 0.6% | 5.2% | 8.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,536.0 Cr | 4.3% | -0.7% | -11.4% | Stock Analytics |
LACTOSE (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LACTOSE (INDIA) | 0.8% |
-1.1% |
-42.5% |
SENSEX | -0% |
-2.1% |
1.1% |
You may also like the below Video Courses